ConductScience.org, home

Paper9367397

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.

Isaacs JD and 10 others. Clin Exp Immunol, 1997. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease. Papers, record 9367397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9367397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2019-05-12
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Isaacs JDJ D
2Burrows NN
3Wing MM
4Keogan MTM T
5Rebello PRP R
6Watts RAR A
7Pye RJR J
8Norris PP
9Hazelman BLB L
10Hale GG
11Waldmann HH

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Arthritis, RheumatoidMajor topic
CD4 AntigensMajor topic
PsoriasisMajor topic
Adolescent
Adult
Aged
Animals
Antibodies, Bispecific
Autoimmune Diseases
Female
Humans
Immunotherapy
Male
Middle Aged
Rats

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12496159A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha.J Immunol1989https://conductscience.org/library/papers/2496159PubMed
29358610Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.Ther Immunol1995https://conductscience.org/library/papers/9358610PubMed
32311645Complement activation by immunoglobulin does not depend solely on C1q binding.Eur J Immunol1990https://conductscience.org/library/papers/2311645PubMed
46229268T-cell subpopulations in the blood and skin of patients with psoriasis.Br J Dermatol1984https://conductscience.org/library/papers/6229268PubMed
52938014Induction of tolerance by monoclonal antibody therapy.Nature1986https://conductscience.org/library/papers/2938014PubMed
63486938Tolerance to rat monoclonal antibodies. Implications for serotherapy.J Exp Med1986https://conductscience.org/library/papers/3486938PubMed
73090139Induction of immune tolerance by administration of monoclonal antibody to L3T4.J Immunol1986https://conductscience.org/library/papers/3090139PubMed
83097122Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.J Immunol1986https://conductscience.org/library/papers/3097122PubMed
93500259Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.J Exp Med1987https://conductscience.org/library/papers/3500259PubMed
103127726Reshaping human antibodies for therapy.Nature1988https://conductscience.org/library/papers/3127726PubMed
113358796The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum1988https://conductscience.org/library/papers/3358796PubMed
123260935Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.J Exp Med1988https://conductscience.org/library/papers/3260935PubMed
132973413Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.Eur J Immunol1988https://conductscience.org/library/papers/2973413PubMed
142647894Induction of classical transplantation tolerance in the adult.J Exp Med1989https://conductscience.org/library/papers/2647894PubMed
152319138A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinants.J Immunol Methods1990https://conductscience.org/library/papers/2319138PubMed
162109379In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids.Transplantation1990https://conductscience.org/library/papers/2109379PubMed
172366834Monoclonal-antibody therapy in systemic vasculitis.N Engl J Med1990https://conductscience.org/library/papers/2366834PubMed
181994909Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.Arthritis Rheum1991https://conductscience.org/library/papers/1994909PubMed
192025306Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.Arthritis Rheum1991https://conductscience.org/library/papers/2025306PubMed
201903536Reshaping a therapeutic CD4 antibody.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1903536PubMed

See all 49 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
34162832AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia.Blood Cancer J2021https://conductscience.org/library/papers/34162832PubMed
32424240Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.Acta Pharmacol Sin2020https://conductscience.org/library/papers/32424240PubMed
24679538In search of magic bullets: the golden age of immunotherapeutics.Cell2014https://conductscience.org/library/papers/24679538PubMed
20732645Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets.Best Pract Res Clin Rheumatol2010https://conductscience.org/library/papers/20732645PubMed
15210644Psoriasis and the new biologic agents: interrupting a T-AP dance.CMAJ2004https://conductscience.org/library/papers/15210644PubMed
12598373Biologic therapies for juvenile arthritis.Arch Dis Child2003https://conductscience.org/library/papers/12598373PubMed
11123030Biologic therapies in rheumatoid arthritis.Curr Rheumatol Rep1999https://conductscience.org/library/papers/11123030PubMed
10535846Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.Br J Ophthalmol1999https://conductscience.org/library/papers/10535846PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9367397

GET https://conductscience.org/api/papers/v1/9367397/references?page=2